GGHC
SGHT icon

Gilder Gagnon Howe & Co’s Sight Sciences SGHT Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,527
Closed -$445K – 256
2022
Q2 		$445K Sell
49,527
-10
-0% -$88 0.01% 225
2022
Q1 		$573K Buy
49,537
+15,688
+46% +$241K 0.01% 265
2021
Q4 		$595K Sell
33,849
-54
-0.2% -$1.19K ﹤0.01% 317
2021
Q3 		$770K Buy
+33,903
New +$1.11M ﹤0.01% 330

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Gilder Gagnon Howe & Co's SGHT Position: Q3 2022 in Review

Gilder Gagnon Howe & Co sold out of Sight Sciences (SGHT) in Q3 2022, closing a stake of 49,527 shares — an estimated $445K sold.

Gilder Gagnon Howe & Co first reported a position in SGHT in Q3 2021 and held it in 4 quarters. The position peaked at $770K in Q3 2021. 68 funds tracked by Wall St. Rank hold SGHT as of Q3 2022.

  • Gilder Gagnon Howe & Co reported no remaining Sight Sciences position as of Q3 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 49,527 Sight Sciences shares in Q3 2022, an estimated $445K.
  • Gilder Gagnon Howe & Co first reported a position in Sight Sciences in Q3 2021 and held it in 4 quarters.
  • Gilder Gagnon Howe & Co's Sight Sciences position peaked at $770K in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.